Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NSC-CRAd-Survivin-pk7 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
NSC-CRAd-Survivin-pk7 is a virotherapy comprised of an oncolytic virus driven by the survivin promoter and delivered via allogeneic neural stem cells, potentially resulting in reduced tumor burden and a cytotoxic effect in tumor cells expressing survivin (PMID: 30719498). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| NSC-CRAd-Survivin-pk7 | NSC-CRAd-Survivin-pk7 | 0 | 1 |